Top Markets
Coin of the day
Petros Pharmaceuticals, Inc. Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc.

PTPI
Peringkat dalam Saham #40451
Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male... Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male health solutions. Their activities include both the commercialization and ongoing development of Stendra, a prescription PDE-5 inhibitor specifically designed for treating erectile dysfunction (ED). Furthermore, Petros is advancing H100, a proprietary topical formulation currently in development as a potential treatment for acute Peyronie's disease. The company's offerings also extend to a range of erectile dysfunction products, such as vacuum erection devices. Petros Pharmaceuticals, Inc. operates from its base in New York, New York.
Harga Saham
$0.0034
Kapitalisasi Pasar
$144.07K
Perubahan (1 hari)
13.33%
Perubahan (1 tahun)
-88.67%
Negara
US
Perdagangan Petros Pharmaceuticals, Inc. (PTPI)

Kategori

Riwayat hasil dividen untuk Petros Pharmaceuticals, Inc. (PTPI)
Hasil dividen (TTM) dari Petros Pharmaceuticals, Inc. (simbol saham: PTPI) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Petros Pharmaceuticals, Inc. (PTPI) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing